← Back
$AKRO All transactions

Akero Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$106K

Shares

2,000

Price

$53

Filed

Jul 3

Insider

Name

Lamy Patrick

Title

Senior VP, Commercial Strategy

CIK

0001961273

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

29,891

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person.

Filing Info

Accession No.

0000950170-25-094011

Form Type

4

Issuer CIK

0001744659

Lamy Patrick's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-07-01 AKRO $106K
2025-06-30 AKRO A $5K

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.